Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Infez Med ; 25(3): 270-273, 2017 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-28956546

RESUMEN

Aspergillus myofasciitis is a rare infection of the muscles and their fascial sheaths that has been reported in patients with immune deficiencies of various kinds but, until now, not with chronic granulomatous disease (CGD). Patients affected by CGD are at high risk of invasive aspergillus infections. The case described involves a 14-year-old boy with a severe autosomal recessive CGD who was admitted to hospital with an Aspergillus myofasciitis of the left forearm. He was treated with liposomal amphotericin for 14 days and then with oral voriconazole for three months with an excellent clinical outcome. He did not evidence any recurrence in the following 30 months using itraconazole prophylaxis.


Asunto(s)
Aspergilosis/etiología , Aspergillus fumigatus/aislamiento & purificación , Fascitis/etiología , Enfermedad Granulomatosa Crónica/complicaciones , Piomiositis/etiología , Adolescente , Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Aspergilosis/tratamiento farmacológico , Aspergilosis/microbiología , Aspergilosis/cirugía , Terapia Combinada , Desbridamiento , Quimioterapia Combinada , Fascitis/tratamiento farmacológico , Fascitis/microbiología , Fascitis/cirugía , Antebrazo , Humanos , Interferón gamma/uso terapéutico , Itraconazol/uso terapéutico , Masculino , Piomiositis/tratamiento farmacológico , Piomiositis/microbiología , Piomiositis/cirugía , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico
2.
Scand J Infect Dis ; 46(1): 69-72, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24131423

RESUMEN

We report, in a clinical setting, the tigecycline concentration and area under the concentration-time curve (AUC) - both in blood and in cerebrospinal fluid (CSF) - of a patient with a ventriculo-atrial shunt infection. Tigecycline weakly penetrates CSF the CSF-to-serum concentration ratio was 0.079 and CSF-to-serum AUC(0-12) ratio was 0.067.


Asunto(s)
Antibacterianos/farmacocinética , Líquido Cefalorraquídeo/química , Minociclina/análogos & derivados , Adulto , Antibacterianos/administración & dosificación , Área Bajo la Curva , Infecciones Bacterianas/tratamiento farmacológico , Derivaciones del Líquido Cefalorraquídeo/efectos adversos , Femenino , Humanos , Minociclina/administración & dosificación , Minociclina/farmacocinética , Plasma/química , Tigeciclina
3.
New Microbiol ; 35(2): 245-7, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22707140

RESUMEN

We describe a case of a 66-year-old immunocompetent man affected by Achromobacter denitrificans renal abscess related to renal stones. The patient was treated successfully with meropenem 1 g three times daily for 60 days. To our knowledge, this is the first ever case reported of Achromobacter denitrificans renal abscess.


Asunto(s)
Absceso/microbiología , Achromobacter denitrificans/aislamiento & purificación , Enfermedades Renales/microbiología , Achromobacter denitrificans/genética , Anciano , Antibacterianos/uso terapéutico , Humanos , Enfermedades Renales/tratamiento farmacológico , Masculino , Meropenem , Tienamicinas/uso terapéutico
4.
Infez Med ; 19(3): 147-51, 2011 Sep.
Artículo en Italiano | MEDLINE | ID: mdl-22037434

RESUMEN

We present the case of an asymptomatic Loa loa disease in a 28-year-old Nigerian man living in Italy for 5 years. The man was admitted to our clinic for an occasional identification of hypereosinophilia (white blood cell count 5440/mmc, eosinophil 42%) and the presence of microfilaria at an hemoscopic evaluation. The diagnosis was made by testing the diurnal peripheral blood that showed a parasitaemia of 7000 microfilia/mL. The patient was treated with ivermectin 12 mg on the first day followed by albendazole 400 mg every 12 hours for 21 days with a reduction but no negativization of the parasitaemia and no collateral effect. Filariasis should be considered in all patients who come from or have stayed in endemic areas or who present alterations in the leukocyte formula, including hypereosinophilia, or some unexplainable allergic disorders. The lab diagnosis can be conducted through a hemoscopic test or directly with the identification of the adult worm, whereas the parasitaemia can be evaluated only through a hemoscopic test. The therapy can be non-conclusive or carried out with difficulty as finding diethylcarbamazine may be a hard task or potentially fatal anaphylactic reactions may occur.


Asunto(s)
Albendazol/uso terapéutico , Antinematodos/uso terapéutico , Ivermectina/uso terapéutico , Loa/aislamiento & purificación , Loiasis/diagnóstico , Loiasis/tratamiento farmacológico , Adulto , Animales , Dietilcarbamazina/efectos adversos , Dietilcarbamazina/provisión & distribución , Dípteros , Quimioterapia Combinada , Eosinofilia/sangre , Filaricidas/uso terapéutico , Humanos , Loiasis/sangre , Loiasis/transmisión , Masculino , Resultado del Tratamiento
5.
Ann Clin Microbiol Antimicrob ; 10: 26, 2011 Jun 09.
Artículo en Inglés | MEDLINE | ID: mdl-21658248

RESUMEN

BACKGROUND: There is no clear relationship between in vitro bactericidal activity tests and clinical outcome. We studied bactericidal activity of oxacillin, vancomycin and teicoplanin against Staphylococcus aureus isolates in patients with endocarditis and then we sought to determine if there was a relationship between in vitro bactericidal activity and clinical outcome. METHODS: Minimal bacteriostatic and minimal bactericidal concentrations were determined for Staphylococcus aureus strains isolated from patients with endocarditis following standardized methods. Medical records were reviewed retrospectively to collect data on antimicrobial susceptibility at admission, antimicrobial therapy, need for surgery, embolic events and outcome. RESULTS AND DISCUSSION: Sixty-two Staphylococcus aureus strains were studied in 62 patients with endocarditis. Overall, 91.9% definite, 21% methicillin resistant and 72.6% cured. Surgery was performed in 32.3% and embolic events were documented in 64.5%. Tolerance to oxacillin and teicoplanin was more common than vancomycin tolerance among methicillin susceptible Staphylococcus aureus. Among methicillin resistant Staphylococcus aureus teicoplanin was shown to have a higher rate of tolerance than vancomycin. No statistically significant differences on clinical outcome between oxacillin tolerant and oxacillin non tolerant Staphylococcus aureus infections were observed. Tolerance to oxacillin did not adversely affect clinical outcomes of patients with methicillin susceptible Staphylococcus aureus endocarditis treated with a combination of antimicrobials including oxacillin. The cure rate was significantly lower among patients with methicillin resistant Staphylococcus aureus endocarditis. CONCLUSIONS: In vitro bactericidal test results were not valid predictors of clinical outcome. Physicians need to use additional parameters when treating patients with staphylococcal endocarditis.


Asunto(s)
Antibacterianos/uso terapéutico , Endocarditis Bacteriana/tratamiento farmacológico , Glicopéptidos/uso terapéutico , Oxacilina/uso terapéutico , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus/efectos de los fármacos , Adulto , Antibacterianos/farmacología , Farmacorresistencia Bacteriana , Quimioterapia Combinada , Endocarditis Bacteriana/microbiología , Femenino , Glicopéptidos/farmacología , Humanos , Masculino , Oxacilina/farmacología , Estudios Retrospectivos , Prueba Bactericida de Suero , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/aislamiento & purificación , Resultado del Tratamiento
6.
Mediterr J Hematol Infect Dis ; 3(1): e2011010, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21625314

RESUMEN

Hepatitis B virus (HBV) infection constitutes a serious global health problem. Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B. We present here a case of a 62-year-old man affected by severe acute hepatitis B with progressive worsening of clinical and hepatic function. The patient was treated with entecavir without critical side effects. We observed rapid clinical and laboratory improvements and the disappearance of hepatitis B surface antigen (HBsAg). The treatment with entecavir was protracted until 17(th) week when the antibody anti-HBs appeared. Entecavir should be carefully considered for the treatment of severe acute hepatitis B cases.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA